Report #2836131

Received Apr 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NJ
Recovered: Unknown
Vaccinated: Feb 17, 2025
Onset: Mar 17, 2025
Days to onset: 28
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RV5	ROTAVIRUS (ROTATEQ)	MERCK & CO. INC.	UNK	X023474	OT

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; ROTATEQ was administered after a temperature excursion; Information has been received from Business Partner/CRO on 21-Mar-2025. This spontaneous report was received from a Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-Feb-2025, the patient was vaccinated with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), (lot #X023474, expiration date: 11-Jul-2025) administered by Oral route for prophylaxis. Tis vaccine underwent temperature excursion in 52.2 degree Fahrenheit for 1 hour. No additional adverse event was reported.